U.S. RESEARCH ROUNDUP- Equinix, KLA, WW Grainger
Brief: Lite Strategy Inc - On Nov 14, Board Approves Justin J. File As Permanent CEO - SEC Filing
Brief: Lite Strategy Reports First Quarter Fiscal Year 2026 Results Highlights Successful Launch Of $100M Litecoin Treasury Strategy And Movement Into Active Capital Market Operations
Brief: Lite Strategy Announces $25M Share Repurchase Program, Signaling Shift From Initial Litecoin Accumulation To Active Capital Market Operations
Brief: MEI Pharma, Inc. Rebrands as Lite Strategy, Inc., Adopts New NASDAQ Ticker ‘LITS’
Brief: MEI Pharma Acquires Litecoin, Launches $100M Institutional Treasury Strategy
Brief: MEI Pharma Files For Common Stock Offering Of Up To $100 Million - SEC Filing
MEI Pharma soars after $100 million raise to buy litecoin
U.S. RESEARCH ROUNDUP- Alphabet, Booking Holdings, Meta
Brief: MEI Pharma Reports Third Quarter Fiscal Year 2025 Cash Position
U.S. RESEARCH ROUNDUP- BlackRock, Morgan Stanley, ServiceNow
Brief: Mei Pharma Inc QTRLY Net Loss Per Share $0.40
Brief: MEI Pharma Reports Fiscal Year End 2024 Cash Position
Brief: MEI Pharma Begins Evaluation Of Strategic Alternatives
U.S. STOCKS ON THE MOVE-Walt Disney, Mattel, Tellurian
U.S. STOCKS ON THE MOVE-Verizon Communications, Reddit, Starbucks
MEI Pharma rises on workforce reduction plan
Brief: MEI Pharma To Consider Strategic Alternatives
MEI Pharma Inc reports results for the quarter ended in March - Earnings Summary